Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Critical Path To Payment? Venture Capitalists Seek Medicare Refocus

This article was originally published in The Gray Sheet

Executive Summary

The National Venture Capital Association is lobbying CMS to make better use of its Council on Technology & Innovations to streamline and standardize the reimbursement process for novel technologies

You may also be interested in...



Medicare Process For New Tech Could Be More Predictable, Weems Admits

CMS Acting Administrator Kerry Weems says the agency should develop a more streamlined and predictable process for new technology reimbursement

Medicare Process For New Tech Could Be More Predictable, Weems Admits

CMS Acting Administrator Kerry Weems says the agency should develop a more streamlined and predictable process for new technology reimbursement

VC White Paper Calls For CMS “Roadmap,” More Active Tech Council

Venture capitalists continue pushing CMS to develop a "roadmap" of its coverage, coding and payment procedures in a 1white paper issued last month

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023986

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel